Analysts say signs point to an approval for the Cambridge company’s gene therapy for a rare muscle disorder — but the decision won’t come without criticism from some in the industry.
Source link
La Potencia Mas Caliente
Analysts say signs point to an approval for the Cambridge company’s gene therapy for a rare muscle disorder — but the decision won’t come without criticism from some in the industry.
Source link